In real-world conditions, patients achieved a mean weight loss of 7.88 %, with a median weight loss of 5.9 %
International Journal of Obesity, 34(4), 659-669
GLP-1 drugs have become some of the most talked-about medications in recent years, helping millions of people manage type 2 diabetes and obesity
Muscle preservation: Because AOD 9604 targets adipose tissue specifically and does not suppress systemic anabolic signaling, researchers have hypothesized that it may allow for fat loss with less collateral impact on lean mass, though this has not been formally tested in head-to-head trials
Understanding approved injection sites, proper technique, and site rotation helps ensure optimal medication delivery and treatment outcomes
FDA NEWS RELEASE